PartsTable
Technical Data Sheet
Download PDF

NDC50242-0044-13 — ALTEPLASE FOR INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC50242-0044-13: ALTEPLASE FOR INJECTION.

The ALTEPLASE FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: FREEZE-DRIED POWDER, features_provided: THINNER AND STERILE, primary_container_type: VIAL, SINGLE DOSE, primary_container_content_quantity: 50.000 MILLIGRAMS OF ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: ALTEPLASE FOR INJECTION 50MG VIAL AND 50ML VIAL STERILE WATER. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-279-5288, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC50242-0044-13
NSN: 6505-01-279-5288
FSC: 6505 — Drugs and Biologicals
CAGE: 1HZ12 — GENENTECH INC (USA)
SPECIFICATIONS
physical_formFREEZE-DRIED POWDER
features_providedTHINNER AND STERILE
primary_container_typeVIAL, SINGLE DOSE
total_primary_container_quantity1
primary_container_content_quantity50.000 MILLIGRAMS OF ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyALTEPLASE FOR INJECTION 50MG VIAL AND 50ML VIAL STERILE WATER
NSN6505-01-279-5288
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available ALTEPLASE FOR INJECTION TITLE COMPONENT PN NDC50242-0044-13 MFR ALTEPLASE FOR INJECTIO
KEY FEATURES
•
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLIGRAMS OF ACTIVE INGREDIENT
•
FEATURES PROVIDED: THINNER AND STERILE
•
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
•
PHYSICAL FORM: FREEZE-DRIED POWDER
•
TOTAL PRIMARY CONTAINER QUANTITY: 1
TECHNICAL CHARACTERISTICS
PRIMARY CONTAINER CONTENT QUANTITY50.000 MILLIGRAMS OF ACTIVE INGREDIENT
FEATURES PROVIDEDTHINNER AND STERILE
PRIMARY CONTAINER TYPEVIAL, SINGLE DOSE
PHYSICAL FORMFREEZE-DRIED POWDER
SPECIAL FEATURES50MG ALTEPLASE EQUIVALENT TO 29 MILLION I.U.; ALSO CONTAINS 1.7GM L-ARGININE,0.5GM PHOSPHORIC ACID,AND LESS THAN 4MG POLYSCORBATE 80; RECOMBINANT; W/ONE 50ML VIAL OF STERILE WATER FOR INJECTION,USP,PER PACKAGE
PART NAME ASSIGNED BY CONTROLLING AGENCYALTEPLASE FOR INJECTION 50MG VIAL AND 50ML VIAL STERILE WATER
TOTAL PRIMARY CONTAINER QUANTITY1
SUBSTITUTES & CROSS-REFERENCES 1
ACTIVASEReference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusCancelled· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC50242-0044-13?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC50242-0044-13?
NDC50242-0044-13 is a ALTEPLASE FOR INJECTION.
What parts can replace NDC50242-0044-13?
There is 1 known substitute for NDC50242-0044-13: ACTIVASE. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC50242-0044-13?
NDC50242-0044-13 is cataloged in the U.S. Government catalog under NSN 6505-01-279-5288. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC50242-0044-13